| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |